Health & Nutrition
Here are the 5 price-target changes and 4 trades we made...
Many of these moves stemmed from what we saw in quarterly numbers and heard on conference...
Pfizer limits distribution of some drugs from North Carolina...
Pfizer's Rocky Mount facility supplies 8% of all sterile injectable medicines used...
Troubled health name bounces after strong quarter and guidance....
An initial nearly 9% rally in BHC to over $10 per share faded somewhat as investors...
Infant RSV shot wins CDC backing, paving way for fall availability
Sanofi has said the companies are prepared to roll the shot out before RSV season...
Moderna raises Covid vaccine outlook despite sharp drop...
Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of...
Humana calms Wall Street's jitters with quarterly results,...
Humana's second-quarter numbers and forward commentary boost our confidence in the...
GSK sues Pfizer claiming RSV vaccine patent infringement
Both RSV vaccines were approved by the U.S. Food and Drug Administration for use...
Moderna shares rise on better Covid vaccine outlook despite...
Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of...
Infant RSV shot faces final hurdle at CDC, could be available...
Sanofi has said the companies are prepared to roll the shot out before RSV season...
FDA warns some Tydemy birth control pills may not be effective,...
The pills tested low for ascorbic acid, which could reduce their effectiveness and...
